Attention deficit hyperactivity disorder (ADHD) is the so-called the most frequently diagnosed neurological disorder in children in Australia.
It has been the subject of controversy over the years regarding its potential wrong diagnosis and overdiagnosis. There were also differences in levels of diagnosis and drug prescription, depending on Where do you live and yours socioeconomic status.
To address these concerns and improve consistency in diagnosing and prescribing ADHD, the Australasian Association of ADHD Professionals has published a recent prescribing guide. This will assist healthcare professionals consistently provide the right treatment to the right people, with the right mix of medical and non-medical support.
Here’s how ADHD medication prescribing has changed over time and what the recent guidelines mean.
What is ADHD and how is it treated?
Until one in ten young Australians experience ADHD. It is diagnosed as a result of lack of attention, hyperactivity and impulsivity, which has negative consequences at home, school or work.
The main pillar of ADHD treatment are psychostimulants.
However, an internationally recognized approach is to combine medicines with non-medical interventions in: multimodal approach. These nonmedical interventions include cognitive behavioral therapy (CBT), occupational therapy, educational strategies, and other supports.
The exploit of medications has changed over time
In Australia, Ritalin (methylphenidate) was originally the most popular drug. prescribed medication for ADHD. This changed in the 1990s after the introduction of dexamphetamine and subsequent years Vyvance availability (lisdexamfetamine).
Perhaps the most significant change has occurred with slow-release versions of the above drugs, which can last over eight hours (longer than the school day).
By following clinical guidelines, prescribing medications for ADHD is a unthreatening practice. However, the exploit of amphetamines to treat youthful people with ADHD has raised public concern. This highlights the importance of consistent guidelines for prescribers.
Developments in diagnostics and drug prescribing
Starting from a low base, the 1990s saw a dramatic escalate in addiction diagnoses and treatment. Most of them were supervised by A a small number of psychiatrists and pediatricians in any state or territory. While this initially provided the potential for consistency, it also raised concerns about best practices.
This led to the development of the first clinical guidelines for ADHD in 1997 by the National Medical Health and Research Council.
Several refinements were then made as the recipes expanded change of diagnostic criteria (expanding to include dual diagnosis with autism) and the need for best practice as GP prescribing increases. These guidelines increased consistency in approaches at the national level and reduced the likelihood of misdiagnosis or overdiagnosis.
However recent Senate inquiry In the five years to 2022, drug diagnoses and treatment rates continued to escalate significantly. It highlights the need for a more consistent approach to diagnosis and prescribing.
First the ingredients, then the recipe
Latest clinical guidelinesreleased by the Australasian Association of ADHD Professionals in 2022, outlined an action plan for ADHD clinical practice, research and policy. They did this by drawing on the lived experiences of people with ADHD. They also highlighted broader health issues, such as responding to ADHD as a holistic condition.
It remains challenging predict individual response to various drugs. That’s why the recent Prescribing Guide provides practical advice on how to prescribe medicines safely and responsibly. This is intended to reduce the risk of inappropriate prescription, dosing and titration of ADHD medications across age groups, settings and individuals.
Figuratively speaking, clinical guidelines describe what the ingredients of a cake should be, while prescribing guidelines provide step-by-step recipes.
So what do they recommend?
An critical principle contained in both documents is that medications should not be the first and only treatment. Not every medicine works the same for every child. In some cases they don’t work at all.
Possible side effects of medications vary and include loss of appetite, sleep problems, headaches, abdominal pain, mood swings and irritability. These guidelines assist adjust medications to reduce these side effects.
Medicines represent an critical opportunity for many youthful people to make the most of psychosocial and psychoeducational support. This support may include:
Support for ADHD may also include parent training. However, this does not mean that parents cause ADHD. On the contrary, they may support more effective treatment, especially since the challenging symptoms of ADHD can be challenging even for the “perfect” parent.
Getting the right diagnosis
There are reports of people wanting to take advantage TikTok for self-diagnosisand an escalate in the number of people using over-the-counter ADHD stimulants.
However, the message from these recent guidelines is that diagnosing ADHD is a elaborate process that takes professionals at least three hours. Online sources can be useful in encouraging people to seek assist, but the diagnosis should be made by a qualified health care professional.
Finally, although we have moved beyond the unhelpful debate about whether ADHD is real and have established best diagnostic and prescribing practice, there is still much work to be done in reducing stigma and changing negative community attitudes towards ADHD.
Let’s hope that in the future we will be able to better cultivate diversity and difference and not just see it as a deficit.